Literature DB >> 20177061

A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.

Evelyn C Nieves1, Naveen Manchanda.   

Abstract

Urokinase plasminogen activator receptor (u-PAR) binds urokinase plasminogen activator (u-PA) and participates in plasminogen activation in addition to modulating several cellular processes such as adhesion, proliferation, and migration. u-PAR is susceptible to proteolysis by its cognate ligand and several other proteases. To elucidate the biological significance of receptor cleavage by u-PA, we engineered and expressed a two-chain urokinase plasminogen activator (tcu-PA) cleavage-resistant u-PAR (cr-u-PAR). This mutated receptor was similar to wild-type u-PAR in binding u-PA and initiating plasminogen activation. However, cr-u-PAR exhibited accelerated internalization and resurfacing due to direct association with the endocytic receptor alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein in the absence of the enzyme x inhibitor complex of tcu-PA and plasminogen activator inhibitor-1 (tcu-PA.PAI-1). cr-u-PAR-expressing cells had enhanced migration compared with wild-type u-PAR-expressing cells, and cr-u-PAR was less sensitive to chymotrypsin cleavage as compared with wt u-PAR. Our studies suggest that these mutations in the linker region result in a rearrangement within the cr-u-PAR structure that makes it resemble its ligand-bound form. This constitutively active variant may mimic highly glycosylated cleavage-resistant u-PAR expressed in certain highly malignant cancer-cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177061      PMCID: PMC2857136          DOI: 10.1074/jbc.M109.008581

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

Authors:  Cyril Barinka; Graham Parry; Jennifer Callahan; David E Shaw; Alice Kuo; Khalil Bdeir; Douglas B Cines; Andrew Mazar; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

2.  Cell-surface acceleration of urokinase-catalyzed receptor cleavage.

Authors:  G Høyer-Hansen; M Ploug; N Behrendt; E Rønne; K Danø
Journal:  Eur J Biochem       Date:  1997-01-15

3.  A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

Authors:  F Fazioli; M Resnati; N Sidenius; Y Higashimoto; E Appella; F Blasi
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

4.  Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration.

Authors:  Chunzhang Cao; Daniel A Lawrence; Yang Li; Christine A F Von Arnim; Joachim Herz; Enming J Su; Alexandra Makarova; Bradley T Hyman; Dudley K Strickland; Li Zhang
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

5.  Regulation of integrin function by the urokinase receptor.

Authors:  Y Wei; M Lukashev; D I Simon; S C Bodary; S Rosenberg; M V Doyle; H A Chapman
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

6.  Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region.

Authors:  Henrik Gårdsvoll; Michael Ploug
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

7.  Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.

Authors:  A Nykjaer; L Kjøller; R L Cohen; D A Lawrence; B A Garni-Wagner; R F Todd; A J van Zonneveld; J Gliemann; P A Andreasen
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

8.  Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains.

Authors:  N Behrendt; E Ronne; K Dano
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

9.  Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes.

Authors:  A Nykjaer; M Conese; E I Christensen; D Olson; O Cremona; J Gliemann; F Blasi
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

10.  alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.

Authors:  M Conese; A Nykjaer; C M Petersen; O Cremona; R Pardi; P A Andreasen; J Gliemann; E I Christensen; F Blasi
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more
  4 in total

1.  Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.

Authors:  Torry A Tucker; LaTerrica Williams; Kathleen Koenig; Hema Kothari; Andrey A Komissarov; Galina Florova; Andrew P Mazar; Timothy C Allen; Khalil Bdeir; L Vijaya Mohan Rao; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02       Impact factor: 6.914

2.  Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor.

Authors:  Henrik Gårdsvoll; Magnus Kjaergaard; Benedikte Jacobsen; Mette C Kriegbaum; Mingdong Huang; Michael Ploug
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

3.  Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assembly.

Authors:  Lingyan Wang; Benjamin S Pedroja; Erin E Meyers; Angelo L Garcia; Sally S Twining; Audrey M Bernstein
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

4.  Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.

Authors:  Synnøve Magnussen; Elin Hadler-Olsen; Nadezhda Latysheva; Emma Pirila; Sonja E Steigen; Robert Hanes; Tuula Salo; Jan-Olof Winberg; Lars Uhlin-Hansen; Gunbjørg Svineng
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.